NMRA
Neumora Therapeutics, Inc.
0.00 (0.00%)0.77USD1.7M成交股數145M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 29.3M | 38.6M | 40.5M | 38.7M | 52.2M | 45.9M | 60.6M | 48.6M | 45.8M | 41.6M | 32.8M | 29.5M |
| 銷售管理費用 | 12.9M | 14.3M | 12.2M | 15.3M | 18.8M | 17.0M | 16.0M | 15.2M | 14.3M | 15.3M | 9.3M | 9.7M |
| 營業利益 | −42.2M-41% | −52.9M-16% | −57.7M-25% | −54.0M-15% | −70.9M+18% | −62.9M+11% | −76.6M+82% | −63.8M+63% | −60.1M | −56.9M | −42.1M | −39.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −43.1M-37% | −53.5M-112% | −56.8M-22% | −52.7M-10% | −68.0M+27% | 429M-909% | −72.5M+88% | −58.7M+65% | −53.7M | −53.0M | −38.5M | −35.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.23-45% | -0.30-19% | -0.35-22% | -0.33-11% | -0.42+24% | -0.37-68% | -0.45-65% | -0.37-70% | -0.34 | -1.14 | -1.28 | -1.22 |
| 稀釋股數 | 185M | 180M | 162M | 162M | 161M | 159M | 160M | 159M | 158M | 46.7M | 30.1M | 29.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 117M | 147M | 129M | 125M | 127M | 142M | 276M | 151M | 183M | 412M | 204M | 211M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 125M | 154M | 178M | 224M | 257M | 317M | 353M | 404M | 450M | 545M | – | – |
| 有息負債 | 52.9M | 53.0M | 19.6M | 19.5M | – | 0.00 | – | – | – | – | – | – |
| 總負債 | 80.7M | 83.2M | 45.7M | 40.9M | 28.4M | 29.9M | 31.8M | 23.2M | 25.7M | 32.1M | – | – |
| 股東權益 | 44.5M | 70.7M | 132M | 183M | 228M | 287M | 321M | 381M | 425M | 513M | −514M | −478M |
| 負債比 | 64.5% | 54.1% | 25.7% | 18.3% | 11.1% | 9.4% | 9.0% | 5.7% | 5.7% | 5.9% | – | – |
| 淨現金(現金 − 有息負債) | 63.9M | 94.1M | 110M | 105M | – | 142M | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −46.4M | – | – | −59.4M+38% | – | – | – | −43.0M | – | – | −33.0M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | 36K |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | −33.1M |
| 折舊攤銷 | – | 8K | – | – | 157K | – | – | – | 158K | – | – | 158K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | 237M | –% | -1.45 | – |
| FY2024 | – | – | 244M | –% | -1.53 | – |
| FY2023 | – | – | −236M | –% | -3.63 | −163M |
| FY2022 | – | – | −131M | –% | -4.81 | −115M |